Volume 5 Issue 4
Jul.  2014
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2014  >  5(4): 231-236
Yin Dongliang, Sun Chong, Zhu Huanbin, et al. Bone marrow mesenchymal stem cell modified by CTLA4-Ig gene can inhibit the rejection of liver transplantation in rats[J]. ORGAN TRANSPLANTATION, 2014, 5(4): 231-236. doi: 10.3969/j.issn.1674-7445.2014.04.008
Citation: Yin Dongliang, Sun Chong, Zhu Huanbin, et al. Bone marrow mesenchymal stem cell modified by CTLA4-Ig gene can inhibit the rejection of liver transplantation in rats[J]. ORGAN TRANSPLANTATION, 2014, 5(4): 231-236. doi: 10.3969/j.issn.1674-7445.2014.04.008
shu

Bone marrow mesenchymal stem cell modified by CTLA4-Ig gene can inhibit the rejection of liver transplantation in rats

doi: 10.3969/j.issn.1674-7445.2014.04.008

  • Organ Transplantation Center, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China

  • Received Date: 2014-03-27
    Available Online: 2021-01-19
  • Publish Date: 2014-07-15
    Abstract
  •   Objective  To investigate the effects and mechanism of bone marrow mesenchymal stem cell(MSC) modified by cytotoxicity T lymphocyte-associated antigen 4-immunoglobulin (CTLA4-Ig) gene on the rejection of orthotopic liver transplantation(OLT) in rats.   Methods  MSC was infected with recombinant adenoviruses(Ad)5 containing CTLA4-Ig gene. After recombinant Ad-5 containing CTLA4-Ig infected MSC for 72 h, the total proteins were extracted. The protein expression of CTLA4-Ig was assessed by Western-blot. The suppression to lymphocyte proliferation by MSC and transgenic MSC were tested by cell counting kit(CCK)-8 analysis. Forty models of acute rejection after OLT in rats were established by modified Kamada's two-cuff technique, with male Lewis and BN rats serving as liver donors and recipients respectively. Forty recipient rats were randomly divided into 4 groups with 10 rats in each group including control group (group A, only saline solution was injected into portal venous during transplantation), MSC group(group B, MSC was injected into portal venous during transplantation), transgenic MSC group(group C, transgenic MSC was injected into portal venous during transplantation), immunosuppressant group[group D, saline solution was injected into portal venous during transplantation, and ciclosporin(CsA) was administered intramuscularly at a dose of 1.5 mg/(kg·d)for 8 days]. On the 9th day after operation, 5 rats were killed randomly in every group, then the levels of interleukin(IL)-2, interferon(IFN)-γ,IL-4 in peripheral blood were measured and the pathological changes and rejection expression of liver tissues were observed by light microscope. The survival condition of other 5 rats in 4 groups was observed.   Results  After recombinant Ad-5 containing CTLA4-Ig infected MSC for 72 h, the protein expression of CTLA4-Ig gene in MSC infected with Ad5-CTLA4-Ig could be detected by Western-blot.When the ratios of MSC:peripheral blood monouclear cell(PBMC) were 1:10 and 1:20, the rates of suppression to lymphocyte proliferation were 85.60% and 76.69% respectively. When the ratios of transgenic MSC:PBMC were 1:10 and 1:20, the rates of suppression to lymphocyte proliferation were 90.50% and 84.20% respectively. Compared with MSC, MSC infected with Ad5-CTLA4-Ig had stronger effect on suppression to lymphocyte proliferation (P<0.05). The survival time after liver transplantation of rats in group A, B, C, D was (13±3), (41±6), (90±15), (102±18) d respectively. There were significant differences among group A, B, C (P<0.05) and there was no significant difference between group C and D (P>0.05). Compared with group A, the serum levels of IL-4 in group B and C were significantly higher(P<0.05). The serum levels of IL-4 in group C were significantly higher than that in group B (P<0.05). There was no significant difference in the serum levels of IL-4 between group C and D (P>0.05). Compared with group A, the serum levels of IL-2 and IFN-γ in group B and C were lower significantly (P<0.05). The serum levels of IL-2 and IFN-γ in group C were significantly lower than those in group B(both in P<0.05). There were no significant differences in the serum levels of IL-2 and IFN-γ between group C and D(P>0.05). The pathological result of liver tissues of rats showed that the grafts of group A developed severe rejection, and the grafts of group B developed moderate rejection. And the grafts of group C and D developed slight rejection.   Conclusions  MSC infected with recombinant Ad5-CTLA4-Ig can inhabit the rejection in liver transplantation, and the effect is superior to MSC alone.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    陈规划,杨扬,张琪,等.间充质干细胞应用现状及展望[J/CD].中华肝脏外科手术学电子杂志,2013,2(4):1-3.

    Chen GH, Yang Y, Zhang Q, et al. Status and prospect of application of mesenchymal stem cell[J/CD]. Chin J Hepat Surg: Electronic Edition,2013,2(4):1-3.
    [2]
    Kim N, Cho SG. Clinical applications of mesenchymal stem cells[J]. Korean J Intern Med,2013,28(4):387-402. doi: 10.3904/kjim.2013.28.4.387
    [3]
    Wang L, Zhao C, Peng Q, et al. Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel indicators of T-cell immune function in patients with chronic hepatitis B virus infection[J]. Biomed Rep,2014,2(2):270-274. http://cn.bing.com/academic/profile?id=2052521921&encoded=0&v=paper_preview&mkt=zh-cn
    [4]
    Kloog Y, Mor A.Cytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1[J].Mol Cell Biol,2014,34(6):978-988. doi: 10.1128/MCB.01024-13
    [5]
    黎尚荣,高婉菱,池信锦,等.大鼠自体原位肝移植术后早期小肠黏膜损伤的病理及炎症因子变化特点[J].器官移植,2013,4(3):136-140. http://www.organtranspl.com/browse/detail/qkid/64/id/278.html

    Li SR, Gao WL, Chi XJ, et al. Characters of pathology and inflammatory factor of small intestinal mucosa injury at early stage after autologous orthotopic liver transplantation in rats[J]. Organ Transplant,2013,4(3):136-140. http://www.organtranspl.com/browse/detail/qkid/64/id/278.html
    [6]
    王月,牛坚.同种大鼠骨髓间充质干细胞诱导调节性B淋巴细胞的免疫负调节作用[J].中华器官移植杂志,2013,34(7):428-431. http://www.cnki.com.cn/Article/CJFDTOTAL-XDYF200812042.htm

    Wang Y, Niu J. An experimental study on the role of MSCs in inducing regulatory B cells and the underlying mechanisms[J]. Chin J Organ Transplant,2013,34(7):428-431. http://www.cnki.com.cn/Article/CJFDTOTAL-XDYF200812042.htm
    [7]
    Taran R, Mamidi MK, Singh G, et al. In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources[J]. J Biosci,2014,39(1):157-169. doi: 10.1007/s12038-013-9409-5
    [8]
    Ng CP, Mohamed Sharif AR, Heath DE, et al. Enhanced ex vivo expansion of adult mesenchymal stem cells by fetal mesenchymal stem cell ECM[J]. Biomaterials,2014,35(13):4046-4057. doi: 10.1016/j.biomaterials.2014.01.081
    [9]
    Ryan AE, Lohan P, O'Flynn L, et al. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation[J]. Mol Ther,2014,22(3):655-667. doi: 10.1038/mt.2013.261
    [10]
    Casiraghi F, Perico N, Remuzzi G. Mesenchymal stromal cells to promote solid organ transplantation tolerance[J].Curr Opin Organ Transplant, 2013,18(1):51-58. doi: 10.1097/MOT.0b013e32835c5016
    [11]
    Sivanathan KN, Gronthos S, Rojas-Canales D, et al. Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation[J]. Stem Cell Rev,2014, 10(3):351-375. doi: 10.1007/s12015-014-9495-2
    [12]
    Gao L, Liu F, Tan L, et al. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease[J]. Biomaterials,2014,35(11):3582-3588. doi: 10.1016/j.biomaterials.2014.01.008
    [13]
    Vanikar AV, Trivedi HL, Gopal SC, et al. Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation[J]. Ren Fail,2014,36(3):457-460. doi: 10.3109/0886022X.2013.868295
    [14]
    Holubova M, Lysak D, Vlas T, et al. Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment[J]. Biologicals,2014,42(3):139-144. doi: 10.1016/j.biologicals.2014.01.003
    [15]
    Inal A. Immunology of liver transplantation[J]. Exp Clin Transplant, 2014,12(Suppl 1):5-10. doi: 10.6002/ect
    [16]
    Zhang J, Li H, Jiang N, et al. Effects of gene transfer CTLA4Ig and anti-CD40L monoclonal antibody on islet xenograft rejection in mice[J]. Transplant Proc,2010,42(5):1835-1837. doi: 10.1016/j.transproceed.2010.01.065
    [17]
    Hong J, Yeom HJ, Lee E, et al. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents[J]. Transpl Immunol,2013,28(2/3):86-92. http://cn.bing.com/academic/profile?id=2053084899&encoded=0&v=paper_preview&mkt=zh-cn
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (109) PDF downloads(5) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return